Zurich Insurance Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Zurich Insurance Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21,733	Closed	-$3.65M	–	491
2018 Q3	$3.65M	Sell	21,733 -2,487	-10%	-$428K	0.08%	265
2018 Q2	$4.17M	Buy	+24,220	New	+$3.96M	0.09%	265
2017 Q4	–	Sell	-4,421	Closed	-$647K	–	600
2017 Q3	$647K	Sell	4,421 -7,961	-64%	-$1.2M	0.02%	584
2017 Q2	$1.93M	Buy	+12,382	New	+$1.89M	0.05%	400

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Zurich Insurance Group's JAZZ Position: Q4 2018 in Review

Zurich Insurance Group sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2018, closing a stake of 21,733 shares — an estimated $3.65M sold.

Zurich Insurance Group first reported a position in JAZZ in Q2 2017 and held it in 4 quarters. The position peaked at $4.17M in Q2 2018. 417 funds tracked by Wall St. Rank hold JAZZ as of Q4 2018.

Zurich Insurance Group reported no remaining Jazz Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Zurich Insurance Group sold 21,733 Jazz Pharmaceuticals shares in Q4 2018, an estimated $3.65M.
Zurich Insurance Group first reported a position in Jazz Pharmaceuticals in Q2 2017 and held it in 4 quarters.
Zurich Insurance Group's Jazz Pharmaceuticals position peaked at $4.17M in Q2 2018.
417 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2018.

Based on Zurich Insurance Group's 13F filing for Q4 2018, filed 14 Feb 2019.